Free Trial

Payoneer Global (PAYO) Competitors

Payoneer Global logo
$10.85 +0.02 (+0.18%)
(As of 11/20/2024 ET)

PAYO vs. RTO, ALLE, WPP, CART, ULS, MEDP, STN, GLOB, HQY, and BILI

Should you be buying Payoneer Global stock or one of its competitors? The main competitors of Payoneer Global include Rentokil Initial (RTO), Allegion (ALLE), WPP (WPP), Maplebear (CART), UL Solutions (ULS), Medpace (MEDP), Stantec (STN), Globant (GLOB), HealthEquity (HQY), and Bilibili (BILI). These companies are all part of the "business services" industry.

Payoneer Global vs.

Payoneer Global (NASDAQ:PAYO) and Rentokil Initial (NYSE:RTO) are both business services companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, community ranking, earnings, media sentiment, dividends, risk and analyst recommendations.

Payoneer Global received 48 more outperform votes than Rentokil Initial when rated by MarketBeat users. Likewise, 75.00% of users gave Payoneer Global an outperform vote while only 25.00% of users gave Rentokil Initial an outperform vote.

CompanyUnderperformOutperform
Payoneer GlobalOutperform Votes
51
75.00%
Underperform Votes
17
25.00%
Rentokil InitialOutperform Votes
3
25.00%
Underperform Votes
9
75.00%

82.2% of Payoneer Global shares are owned by institutional investors. Comparatively, 9.9% of Rentokil Initial shares are owned by institutional investors. 5.6% of Payoneer Global shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Payoneer Global had 6 more articles in the media than Rentokil Initial. MarketBeat recorded 9 mentions for Payoneer Global and 3 mentions for Rentokil Initial. Payoneer Global's average media sentiment score of 0.86 beat Rentokil Initial's score of 0.11 indicating that Payoneer Global is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Payoneer Global
7 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Rentokil Initial
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Rentokil Initial has higher revenue and earnings than Payoneer Global. Rentokil Initial is trading at a lower price-to-earnings ratio than Payoneer Global, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Payoneer Global$940.30M4.11$93.33M$0.3531.00
Rentokil Initial$5.41B2.40$473.93M$1.4317.97

Payoneer Global currently has a consensus target price of $10.79, indicating a potential downside of 0.59%. Rentokil Initial has a consensus target price of $29.00, indicating a potential upside of 12.84%. Given Rentokil Initial's higher probable upside, analysts plainly believe Rentokil Initial is more favorable than Payoneer Global.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Payoneer Global
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
3.14
Rentokil Initial
0 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.43

Payoneer Global has a net margin of 13.82% compared to Rentokil Initial's net margin of 0.00%. Payoneer Global's return on equity of 17.78% beat Rentokil Initial's return on equity.

Company Net Margins Return on Equity Return on Assets
Payoneer Global13.82% 17.78% 1.73%
Rentokil Initial N/A N/A N/A

Payoneer Global has a beta of 0.82, meaning that its share price is 18% less volatile than the S&P 500. Comparatively, Rentokil Initial has a beta of 1.09, meaning that its share price is 9% more volatile than the S&P 500.

Summary

Payoneer Global beats Rentokil Initial on 13 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PAYO vs. The Competition

MetricPayoneer GlobalBusiness services IndustryBusiness SectorNASDAQ Exchange
Market Cap$3.86B$20.97B$6.88B$8.89B
Dividend YieldN/A2.50%2.93%4.06%
P/E Ratio31.0017.7034.1313.30
Price / Sales4.6614.16174.1781.01
Price / Cash31.7834.7325.8136.03
Price / Book5.325.144.775.74
Net Income$93.33M$515.30M$123.71M$225.93M
7 Day Performance5.03%8.27%0.13%-1.32%
1 Month Performance29.63%6.25%8.32%0.60%
1 Year Performance100.93%49.51%30.11%26.23%

Payoneer Global Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PAYO
Payoneer Global
4.1831 of 5 stars
$10.85
+0.2%
$10.79
-0.6%
+99.4%$3.86B$831.10M31.002,167Insider Trade
RTO
Rentokil Initial
1.2041 of 5 stars
$25.70
-1.2%
$29.00
+12.8%
-12.0%$13.14B$6.68B0.0062,900
ALLE
Allegion
4.2489 of 5 stars
$139.43
+0.9%
$144.60
+3.7%
+31.9%$12.12B$3.65B21.4212,400Analyst Revision
WPP
WPP
0.8386 of 5 stars
$51.41
-0.3%
N/A+15.7%$11.71B$18.46B0.00114,732Analyst Downgrade
News Coverage
CART
Maplebear
4.4369 of 5 stars
$41.58
-2.8%
$47.29
+13.7%
+60.9%$10.99B$3.04B27.913,380Analyst Revision
ULS
UL Solutions
2.554 of 5 stars
$52.82
+2.1%
$49.00
-7.2%
N/A$10.35B$2.68B0.0015,233
MEDP
Medpace
4.7711 of 5 stars
$326.09
+3.5%
$380.00
+16.5%
+18.2%$9.79B$1.89B28.555,900
STN
Stantec
3.2074 of 5 stars
$84.13
+1.3%
N/A+19.3%$9.47B$4.80B38.2428,000
GLOB
Globant
4.0595 of 5 stars
$215.70
+3.4%
$229.06
+6.2%
+3.0%$8.99B$2.10B56.3229,150Analyst Forecast
Gap Up
HQY
HealthEquity
3.6708 of 5 stars
$102.96
+0.3%
$107.23
+4.1%
+54.3%$8.97B$999.59M85.803,150News Coverage
BILI
Bilibili
2.2417 of 5 stars
$19.19
+3.6%
$19.69
+2.6%
+31.7%$7.67B$3.19B0.008,801Earnings Report
Analyst Forecast
Gap Up

Related Companies and Tools


This page (NASDAQ:PAYO) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners